Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes

Reps will be promoting Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes.

Think of it as similar to Januvia.

Onglyza (saxagliptin) and Januvia (sitagliptin) are incretin enhancers. They prolong the action of endogenous incretin hormones by blocking their breakdown by the enzyme, dipeptidyl peptidase-4 (DPP-4). This leads to more insulin release after eating.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote